Table 4 Characteristics of pachychoroid neovasculopathy in subretinal hemorrhage group and non- subretinal-hemorrhage group.

	SRH group (n = 20)	Non-SRH group (n = 79)	P value
Gender (men/women)	17/3	62/17	0.517**
Age (years), mean ± SD	66.2 ± 9.5	70.1 ± 7.6	0.053*
Axial length (mm)	23.37 ± 0.91	23.36 ± 0.91	0.959*
Hypertension (%)	8 (40.0)	45 (57.0)	0.174**
Smoking (%)	15 (75.0)	56 (70.9)	0.775**
Follow-up period (months), mean ± SD	35.0 ± 18.9	38.0 ± 17.4	0.525*
Initial conditions
BCVA (logMAR), mean ± SD	0.27 ± 0.55	0.18 ± 0.24	0.455*
Lesion area (mm²), mean ± SD	2.48 ± 3.21	3.50 ± 3.30	0.363*
GLD (µm), mean ± SD	4698 ± 2302	2909 ± 1519	0.005*
CRT (µm), mean ± SD	417.1 ± 365.8	296.7 ± 130.1	0.163*
SFCT (µm), mean ± SD	310.3 ± 53.1	306.9 ± 70.9	0.845*
Polypoidal lesion (%)	17 (85.0)	38 (48.1)	0.004**
CVH (%)	11 (55.0)	45 (57.0)	0.211**
Final conditions
BCVA (logMAR), mean ± SD	0.55 ± 0.60	0.12 ± 0.26	0.005*
CRT (µm), mean ± SD	153.2 ± 99.7	178.7 ± 89.3	0.266*

SRH subretinal hemorrhage; SD standard deviation; BCVA best-corrected visual acuity; GLD greatest linear dimension; CRT central retinal thickness; SFCT subfoveal choroidal thickness; CVH choroidal vascular hyperpermeability.
*Unpaired t-test, **Chi-square test.

Quick links

Search